There’s something fishy going on with omega-3s these days, and it appears that some of the consumer media who reported on the study fell for it – hook, line and sinker. Of course I’m talking about the study that recently published in the Journal of the National Cancer Institutepurporting to identify a positive relationship between higher omega-3 levels and increased risk of prostate cancer. The study quickly generated headlines that fish oil omega-3 supplements may cause prostate cancer.
Lifelong consumption of soy foods may protect against cancers by turning down signalling molecules that encourage cell growth and can lead to tumours, suggests new research in rats.
Omega-3s - in particular eicosapentaenoic acid (EPA) - may offer benefits to people with certain cancers, according to new lab work suggesting that the fatty acids may help kill off cancerous cells.
Metabolic modifications brought about by consumption of high-glucoraphanin broccoli may be behind the suggested health benefits and cancer-fighting ability of the cruciferous vegetable, according to a new clinical trial.
Building consumer and market understanding of the benefits of glucoraphanin from broccoli is a lot like the DHA story, says leading broccoli extract supplier Brassica Protection Products (BPP), as it takes the ‘important step’ of self-affirming the GRAS status of its SGS ingredient.
Fibers from the blue lupin kernel may improve the function of the colon and potential reduce the risk of colon cancer, says a new study from Friedrich Schiller University of Jena in Germany.
Berkley BioSciences Inc. has launched a new formulation of its ActivaMune immune health product, both to improve product performance and to boost sales to help fund ongoing drug development research on the formula’s prime active ingredient—diindolymethane (DIM)—which has been under investigation at the University of California for years.
Reaction to last week’s study linking omega-3 with prostate cancer have been vociferous and near-unanimous in condemning its methods and conclusions. Here Alan Ruth, PhD, and CEO of the Irish Health Trade Association (IHTA), explains why that condemnation was justified and not just sourced from an industry concerned with defending its own patch.
Increasing intakes of omega-3 polyunsaturated fatty acids (PUFAs) could cut the risk of developing breast cancer by up to 14%, according to a meta-analysis of 26 clinical studies.
Increased levels of vitamin B6 are associated with less damage to DNA for men, suggests new data from Japan.
Commercially available frozen broccoli almost entirely lacks the ability to form the beneficial compound sulforaphane from the phytonutrient glucoraphanin, according to new research.
Daily supplements of calcium up to 1000 mg may be associated with reduced mortality for women, says a new study from Canada.
Vitamin C as a cancer treatment adjunct received a boost with the release of recent research results in the May edition of Cancer Chemotherapy and Pharmacology.
Glucosamine and chondroitin supplements, conventionally used for joint health, may have the potential to guard against colorectal cancer, according to researchers.
Two NGOs responsible for safeguarding plants and forests have positively reviewed the harvesting practices of a prostate-benefitting botanical harvested in Cameroon.
Now, almost 20 years after DSHEA became law, some companies seem to be just starting to get the message that the regulations governing health claims language don’t apply just to product labels. Websites are fair game, too, and can form easy pickings for regulators.
Omega-3 fatty acids and their metabolite products may be effective at blocking the growth of cancers – and could be especially effective at inhibiting growth of triple-negative breast cancer tumours, say researchers.
Men and women may benefit from different types of omega-3 fatty acid supplements to reduce their risk of stroke or heart attacks linked to blood clots, says a new study from Australia.
Is 2013 the year for vitamin K2 in the US? A breakthrough study and growing awareness over deficiency point to progress, but consumer awareness is still growing in baby steps for ‘the most fascinating of all vitamins’, says a leading supplier.
Researchers and global media should better consider the validity of single scientific studies that report on supposed ‘miracle foods’ in addition to considering that people do not eat foods or nutrients in isolation, warn researchers.